CPA
VMD icon

Capital Performance Advisors’s Viemed Healthcare VMD Stock Holding History

Capital Performance Advisors’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15
Closed -$110 – 2617
2024
Q3 		$110 Buy
+15
New +$107 ﹤0.01% 2681

Other funds holding VMD

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capital Performance Advisors's VMD Position: Q4 2024 in Review

Capital Performance Advisors sold out of Viemed Healthcare (VMD) in Q4 2024, closing a stake of 15 shares — an estimated $110 sold.

Capital Performance Advisors first reported a position in VMD in Q3 2024 and held it in 1 quarter. The position peaked at $110 in Q3 2024. 141 funds tracked by Wall St. Rank hold VMD as of Q4 2024.

  • Capital Performance Advisors reported no remaining Viemed Healthcare position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 15 Viemed Healthcare shares in Q4 2024, an estimated $110.
  • Capital Performance Advisors first reported a position in Viemed Healthcare in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Viemed Healthcare position peaked at $110 in Q3 2024.
  • 141 funds tracked by Wall St. Rank held Viemed Healthcare as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.